Japan Ministry of Health, Labor and Welfare (MHLW) Grants Marketing Approval For Olumiant(R) (baricitinib) for the Treatment of Rheumatoid Arthritis
INDIANAPOLIS, July 3, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that Japan's Ministry of Health, Labor and Welfare (MHLW) granted marketing approval for Olumia... Biopharmaceuticals, Regulatory Eli Lilly, Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2017 Category: Pharmaceuticals Source Type: news

Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis
Sarilumab is indicated for adults with moderate to severe active rheumatoid arthritis who fail or are intolerant to disease-modifying antirheumatic drugs.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Improving VNS therapy: ElectroCore CEO Amato on gammaCore and its slated July launch
Neuroscience tech developer ElectroCore said recently it plans to launch its handheld gammaCore vagus nerve stimulation device in the US in mid-July, after having won clearance from the FDA in April for treating episodic cluster headaches. Unlike other vagus nerve stimulation devices, the gammaCore is an external handheld device with no implanted component, designed to be used in a pain-free procedure, CEO Frank Amato told MassDevice.com in an interview. “Its a first-of-its-kind type of device,” Amato said, speaking on the recently approved and soon-to-launch gammaCore. “Vagus nerve stimulators have been ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Source Type: news

Parkinson’s disease, arthritis or bowel disease: Can YOU afford to buy prescriptions?
PARKINSON ’S disease, rheumatoid arthritis and inflammatory bowel disease are all types of long-term conditions and sufferers often need constant medication and repeat prescriptions. (Source: Daily Express - Health)
Source: Daily Express - Health - June 28, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: It boosts risk of painful condition sometimes triggered by GARDENING
RHEUMATOID arthritis can have a debilitating effect on the quality of life of sufferers - and, unfortunately, it ’s also a risk factor in another painful condition, tendonitis. (Source: Daily Express - Health)
Source: Daily Express - Health - June 27, 2017 Category: Consumer Health News Source Type: news

Novartis gets European OK for biosimilar of Amgen's Enbrel
ZURICH (Reuters) - Novartis's generics unit Sandoz said the European Commission approved Erelzi, its biosimilar to Amgen's Enbrel, to treat inflammatory diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Mount Sinai, Pfizer renew research collaboration, building on strong foundation
(The Mount Sinai Hospital / Mount Sinai School of Medicine) The Icahn School of Medicine at Mount Sinai and Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) today announced the renewal of an agreement designed to identify and advance new drug candidates linked to major diseases, such as cancer, rheumatoid arthritis, Crohn's disease, colitis, heart failure, Alzheimer's disease, and cystic fibrosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 27, 2017 Category: Cancer & Oncology Source Type: news

Eating Fish May Ease Rheumatoid Arthritis (CME/CE)
(MedPage Today) -- Cross-sectional study ties fish with diminished disease activity (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 26, 2017 Category: American Health Source Type: news

Monotherapy With Biologic DMARDs in Rheumatoid Arthritis Monotherapy With Biologic DMARDs in Rheumatoid Arthritis
Biologic DMARD monotherapy may be a viable treatment alternative for patients with rheumatoid arthritis when combination therapy is not an option.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 26, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Fish Eaters Find Less Rheumatoid Arthritis Pain
Study suggests most fish may play role in controlling symptoms (Source: WebMD Health)
Source: WebMD Health - June 23, 2017 Category: Consumer Health News Source Type: news

Eating fish may significantly reduce rheumatoid arthritis pain
Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 23, 2017 Category: Consumer Health News Source Type: news

Fish Eaters Report Less Rheumatoid Arthritis Pain
Study suggests most fish may play role in controlling symptoms Source: HealthDay Related MedlinePlus Pages: Dietary Fats, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 23, 2017 Category: Consumer Health News Source Type: news

Fish Eaters Report Less Rheumatoid Arthritis Pain
FRIDAY, June 23, 2017 -- Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis, a new study says. Prior studies have shown a beneficial effect of fish oil supplements on rheumatoid... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 23, 2017 Category: General Medicine Source Type: news

EU backs second biosimilar copy of Humira, world's top drug
FRANKFURT (Reuters) - European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a further boost for so-called biosimilars in the region. (Source: Reuters: Health)
Source: Reuters: Health - June 23, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Eating Fish May Reduce Rheumatoid Arthritis Symptoms Eating Fish May Reduce Rheumatoid Arthritis Symptoms
Eating fish two or more times per week was associated with lower disease activity in a cross-sectional analysis of patients with rheumatoid arthritis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Rheumatoid arthritis symptoms: Eating THIS twice a week may reduce joint pain
RHEUMATOID arthritis affects one per cent of the population, but new research has discovered how fish can help relieve painful symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2017 Category: Consumer Health News Source Type: news

Eating Fish May Reduce Rheumatoid Arthritis
Symptoms (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 23, 2017 Category: General Medicine Source Type: news

Eating more fish 'can alleviate rheumatoid arthritis symptoms'
This study indicates that simple changes, such as increasing the amount of fish in their diets, could have a big impact on making the condition more manageable. Lead author Dr Sara Tedeschi, of the division of rheumatology, immunology and allergy at Brigham and Women's Hospital and Harvard Medical School, said:"If our finding holds up in other studies, it suggests that fish consumption may lower inflammation related to rheumatoid arthritis disease activity. "Fish consumption has been noted to have many beneficial health effects, and our findings may give patients with rheumatoid arthritis a strong reason to i...
Source: Arthritis Research UK - June 21, 2017 Category: Rheumatology Source Type: news

Rheumatoid arthritis treatment: THIS may be a new way to cure painful symptoms
RHEUMATOID arthritis affects more than 400,000 people in the UK, but scientists may have found a new way to treat symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - June 21, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Rheumatoid arthritis: Regular fish intake may ease symptoms
Eating more than two portions of fish every week was found to reduce disease activity in patients with rheumatoid arthritis, a new study reveals. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 21, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Filgotinib Combined With MTX in Patients With Active RA Filgotinib Combined With MTX in Patients With Active RA
The addition of filgotinib may be an effective option for patients with active rheumatoid arthritis who did not sufficiently respond to methotrexate alone.Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 21, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Fish as Medicine for Rheumatoid Arthritis
Eating fish may help reduce the joint pain and swelling of rheumatoid arthritis, a new study has found. (Source: NYT Health)
Source: NYT Health - June 21, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Fish and Other Marine Life Rheumatoid Arthritis Joints (Body Part) Methotrexate (Drug) Source Type: news

New gene mutations found in white blood cells in patients with rheumatoid arthritis
(University of Helsinki) Gene mutations accumulating in cells are typical of the development of cancer. Finnish researchers found that a similar accumulation of mutations occurs also in some patients with rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 21, 2017 Category: International Medicine & Public Health Source Type: news

Tocilizumab Triumphs in Methotrexate Combo for RA Tocilizumab Triumphs in Methotrexate Combo for RA
It is not always clear which biologic to add to methotrexate for rheumatoid arthritis, but a new comparison between tocilizumab and a number of TNF inhibitors has some suggestions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Biologics Comparison in Rheumatoid Arthritis Surprises Biologics Comparison in Rheumatoid Arthritis Surprises
A Swedish study had rheumatologists debating the top contenders for second-line therapy in patients with rheumatoid arthritis who do not respond to TNF inhibitor therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Rheumatoid and osteoarthritis symptoms - what is the difference between the conditions?
RHEUMATOID arthritis and osteoarthritis are two different types of arthritis which present different symptoms. But few people know the different between the two conditions. (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2017 Category: Consumer Health News Source Type: news

Biologic-Naive Respond Better to TNF Combination in RA Biologic-Naive Respond Better to TNF Combination in RA
US clinical practice data confirm that combination therapy with TNF inhibitors improves rheumatoid arthritis response compared with monotherapy; however, treatment history makes a difference.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 16, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Children exposed to smoke more likely to develop arthritis
Smokers exposed to cigarette smoke during their childhood years increase their risk of developing rheumatoid arthritis, a groundbreaking French study claims. (Source: the Mail online | Health)
Source: the Mail online | Health - June 16, 2017 Category: Consumer Health News Source Type: news

New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017
Pooled analysis of eight clinical trials shows no difference in serious infection events compared to placebo Results from long-term extension of Phase 3 studies show treatment with baricitinib slows the progression of joint damage and controls disease a... Biopharmaceuticals Eli Lilly, Incyte , Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

Excess risk of cardiovascular events in RA patients decreased since start of 21st century
(European League Against Rheumatism) The results of a meta-analysis presented for the first time today at the Annual European Congress of Rheumatology 2017 press conference showed that the excess risk of cardiovascular events in rheumatoid arthritis (RA) patients relative to the general population has decreased since the year 2000. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

New study shows for first time link between passive smoking in childhood and rheumatoid arthritis
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 press conference confirmed the link between active smoking and the risk of developing rheumatoid arthritis (RA). However, interestingly, it also suggested for the first time that in smokers, exposure to tobacco early in life through passive smoking in childhood significantly increased this risk. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

New relapse prediction tool reduces cost of rheumatoid arthritis treatment
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 have shown that the combined use of two measurements to accurately predict the risk of relapse in patients with rheumatoid arthritis (RA) allows successful dose reduction (tapering) of their disease modifying anti-rheumatic drugs (DMARDs). This in turn increases the cost-effectiveness of each DMARD treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 16, 2017 Category: International Medicine & Public Health Source Type: news

Janssen reports positive long-term results from Phase III trial of sirukumab for RA
Janssen-Cilag International (Janssen) has reported positive long-term results from the Phase III SIRROUND-T clinical trial of sirukumab to treat patients with rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - June 15, 2017 Category: Pharmaceuticals Source Type: news

New Biosimilar for Adalimumab in Rheumatoid Arthritis New Biosimilar for Adalimumab in Rheumatoid Arthritis
A large multinational study compares the efficacy and safety of FKB327 biosimilar to adalimumab in active rheumatoid arthritis. But antidrug antibody levels raise questions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Boehringer Ingelheim presents phase III results demonstrating clinical equivalence of adalimumab biosimilar candidate to HUMIRA ®
Boehringer Ingelheim has announced results from the pivotal Phase III VOLTAIRE®-RA(1) study, confirming that its adalimumab biosimilar candidate BI 695501 and HUMIRA®* have similar efficacy, safety and immunogenicity in patients with moderately-to-severely active rheumatoid arthritis. The 24 week results will be presented at the Annual European Congress of Rheumatology (EULAR 2017) in Madrid. (Source: World Pharma News)
Source: World Pharma News - June 15, 2017 Category: Pharmaceuticals Tags: Featured Boehringer Ingelheim Business and Industry Source Type: news

Biological DMARD guidelines associated with a reduced need for knee and hip replacements in RA
(European League Against Rheumatism) The results of a Danish study presented today at the Annual European Congress of Rheumatology 2017 press conference showed that the incidence of total knee replacements carried out on patients with rheumatoid arthritis started to decrease after the introduction of biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) to national treatment guidelines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2017 Category: International Medicine & Public Health Source Type: news

Rheumatoid arthritis: Being overweight might NOT be a risk factor in men
Rheumatoid arthritis affects one per cent of the UK population, and symptoms include joint pain, stiffness and swelling. (Source: Daily Express - Health)
Source: Daily Express - Health - June 14, 2017 Category: Consumer Health News Source Type: news

Body fat and waist size linked to increased risk of developing rheumatoid arthritis in women
(European League Against Rheumatism) Madrid, Spain, June 14, 2017: The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 showed that, in women, being overweight or obese, as defined by body mass index (BMI ), abdominal obesity and a higher body fat percentage was associated with a higher risk of developing rheumatoid arthritis (RA) (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2017 Category: International Medicine & Public Health Source Type: news

Diet to cure arthritis: Eating THIS part of the Mediterranean diet could suppress symptoms
RHEUMATOID arthritis is a serious and disabling autoimmune disease in which the immune system mistakenly attacks and destroys healthy body tissue. Symptoms can include joint pain and tiredness. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Arthritis drug could cure severe heart condition
Researchers find that drug being tested for the treatment of rheumatoid arthritis may also hold the key to preventing aortic valve stenosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 13, 2017 Category: Consumer Health News Tags: Heart Disease Source Type: news

Tight RA Control Via Tele-health Noninferior to Conventional Clinic Visits Tight RA Control Via Tele-health Noninferior to Conventional Clinic Visits
Tele-health follow-up based on patient-reported outcome (PRO) is noninferior to conventional outpatient care for tight control of disease activity in rheumatoid arthritis (RA) patients with low disease activity or remission, new findings show.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - June 12, 2017 Category: Orthopaedics Tags: Family Medicine/Primary Care News Source Type: news

Truxima (rituximab) for the Treatment of Cancer
ruxima ™ (rituximab) is the first biosimilar monoclonal antibody (mAb) approved for the treatment of haematological cancers, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukaemia, and rheumatoid arthritis, as well… (Source: Drug Development Technology)
Source: Drug Development Technology - June 8, 2017 Category: Pharmaceuticals Source Type: news

Here ’s how vagus nerve stimulation is getting better
A vagus nerve implant with 2 electrodes – one to apply desired stimulation going down into the body, the other to block unwanted stimulation going up to the brain. [Image from Georgia Tech/Rob Felt]Georgia Institute of Technology researchers have reported success targeting vagus nerve stimulation – providing hope for people with a host of inflammatory diseases including rheumatoid arthritis, irritable bowel syndrome and Crohn’s disease. Researchers implanted a pacemaker-like device into rats and showed that it could electrically stimulate the vagus nerve while simultaneously preventing unwanted nerve acti...
Source: Mass Device - June 8, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Implants Research & Development Georgia Institute of Technology MedTech stimulation vagus nerve Source Type: news

AbbVie's Rheumatoid Arthritis Drug Succeeds in Late-stage Trial AbbVie's Rheumatoid Arthritis Drug Succeeds in Late-stage Trial
U.S. drugmaker AbbVie Inc said on Wednesday late-stage data showed its rheumatoid arthritis drug performed better than a placebo in reducing symptoms in moderate-to-severe patients who have not adequately responded to standard treatments.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 8, 2017 Category: Surgery Tags: Rheumatology News Source Type: news

New drug could fight rheumatoid arthritis symptoms - ‘exciting’ results for patients
RHEUMATOID arthritis patients are a step closer to a new, effective treatment following a breakthrough study. Symptoms of rheumatoid arthritis can be painful but experts have hailed the results as 'exciting'. (Source: Daily Express - Health)
Source: Daily Express - Health - June 8, 2017 Category: Consumer Health News Source Type: news

Will Rheumatoid Arthritis Nodules Go Away?
Title: Will Rheumatoid Arthritis Nodules Go Away?Category: Doctor's& Expert's views on SymptomsCreated: 6/8/2017 12:00:00 AMLast Editorial Review: 6/8/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 8, 2017 Category: Rheumatology Source Type: news

What's the Rheumatoid Arthritis Prognosis?
Title: What's the Rheumatoid Arthritis Prognosis?Category: Doctor's& Expert's views on SymptomsCreated: 6/8/2017 12:00:00 AMLast Editorial Review: 6/8/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 8, 2017 Category: Rheumatology Source Type: news

AbbVie's rheumatoid arthritis drug succeeds in trial
(Reuters) - AbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to standard treatments. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie's rheumatoid arthritis drug succeeds in late-stage trial
(Reuters) - U.S. drugmaker AbbVie Inc said on Wednesday its drug to treat moderate-to-severe rheumatoid arthritis met the main goal in a late-stage study. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news